COVID-19 Impact on Global mRNA Vaccine And Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Infectious Disease
  • 1.4.3 Cancer
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Research Institual
• 1.6 Coronavirus Disease 2019 (Covid-19): mRNA Vaccine And Therapeutics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the mRNA Vaccine And Therapeutics Industry
    • 1.6.1.1 mRNA Vaccine And Therapeutics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and mRNA Vaccine And Therapeutics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for mRNA Vaccine And Therapeutics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 mRNA Vaccine And Therapeutics Market Perspective (2015-2026)
• 2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions
  • 2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 mRNA Vaccine And Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 mRNA Vaccine And Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key mRNA Vaccine And Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top mRNA Vaccine And Therapeutics Players by Market Size
  • 3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global mRNA Vaccine And Therapeutics Market Concentration Ratio
  • 3.2.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2019
• 3.3 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
• 3.4 Key Players mRNA Vaccine And Therapeutics Product Solution and Service
• 3.5 Date of Enter into mRNA Vaccine And Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2021-2026)

5 mRNA Vaccine And Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
• 5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 6.2 mRNA Vaccine And Therapeutics Key Players in North America (2019-2020)
• 6.3 North America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 6.4 North America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 7.2 mRNA Vaccine And Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 8.2 mRNA Vaccine And Therapeutics Key Players in China (2019-2020)
• 8.3 China mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 8.4 China mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 9.2 mRNA Vaccine And Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 10.2 mRNA Vaccine And Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 11.2 mRNA Vaccine And Therapeutics Key Players in India (2019-2020)
• 11.3 India mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 11.4 India mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America mRNA Vaccine And Therapeutics Market Size (2015-2020)
• 12.2 mRNA Vaccine And Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Argos Therapeutics
  • 13.1.1 Argos Therapeutics Company Details
  • 13.1.2 Argos Therapeutics Business Overview and Its Total Revenue
  • 13.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction
  • 13.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020))
  • 13.1.5 Argos Therapeutics Recent Development
• 13.2 BioNTech
  • 13.2.1 BioNTech Company Details
  • 13.2.2 BioNTech Business Overview and Its Total Revenue
  • 13.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction
  • 13.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.2.5 BioNTech Recent Development
• 13.3 CureVac
  • 13.3.1 CureVac Company Details
  • 13.3.2 CureVac Business Overview and Its Total Revenue
  • 13.3.3 CureVac mRNA Vaccine And Therapeutics Introduction
  • 13.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.3.5 CureVac Recent Development
• 13.4 eTheRNA
  • 13.4.1 eTheRNA Company Details
  • 13.4.2 eTheRNA Business Overview and Its Total Revenue
  • 13.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction
  • 13.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.4.5 eTheRNA Recent Development
• 13.5 Ethris
  • 13.5.1 Ethris Company Details
  • 13.5.2 Ethris Business Overview and Its Total Revenue
  • 13.5.3 Ethris mRNA Vaccine And Therapeutics Introduction
  • 13.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.5.5 Ethris Recent Development
• 13.6 In-Cell-Art
  • 13.6.1 In-Cell-Art Company Details
  • 13.6.2 In-Cell-Art Business Overview and Its Total Revenue
  • 13.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction
  • 13.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.6.5 In-Cell-Art Recent Development
• 13.7 Moderna Therapeutics
  • 13.7.1 Moderna Therapeutics Company Details
  • 13.7.2 Moderna Therapeutics Business Overview and Its Total Revenue
  • 13.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction
  • 13.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.7.5 Moderna Therapeutics Recent Development
• 13.8 Sangamo Therapeutics
  • 13.8.1 Sangamo Therapeutics Company Details
  • 13.8.2 Sangamo Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction
  • 13.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.8.5 Sangamo Therapeutics Recent Development
• 13.9 Tiba Biotechnology
  • 13.9.1 Tiba Biotechnology Company Details
  • 13.9.2 Tiba Biotechnology Business Overview and Its Total Revenue
  • 13.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction
  • 13.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.9.5 Tiba Biotechnology Recent Development
• 13.10 Translate Bio
  • 13.10.1 Translate Bio Company Details
  • 13.10.2 Translate Bio Business Overview and Its Total Revenue
  • 13.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction
  • 13.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
  • 13.10.5 Translate Bio Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer